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Linezolid is oxazolidinone antibiotic. It inhibits bacterial protein synthesis by 
acting at an early step and a site different from that of other Antimicrobial agents. The 
aim of the present research work was to develop accurate and rapid Differential 
spectrophotometric (Method A) and Area under Curve (Method B) to determine Linezolid 
content in pharmaceutical formulation. Differential spectrophotometric method is 
simplest and rapid technique for altering the spectral properties of analyte with the 
adjustment of the pH by means of aqueous solutions of acid, alkali or buffers. 
Differential spectrophotometry based on the principle of ionization of functional groups 
and pH of the solution. The difference absorption spectra of equimolar solution of 
Linezolid in 0.1M hydrochloric acid in sample cell relative to 0.1M sodium hydroxide in 
reference cell were taken. Area under curve method involves the calculation of integrated 
value of absorbance with respect to the wavelength between the two selected 
wavelengths. Absorption maxima was found 258.27 nm (Method A) and area under curve 
was measured between253-263nm.The drug followed a linear relationship in the range of 
4-20µg/ml; while the correlation coefficient was 0.999(Method A) and 0.9993 (Method B). 
The recovery was 100.01% ±0.17 (Method A) and 99.95 ± 0.33, the relative standard 
deviation for repeatability, intraday and interday was found to be less than 2%. These 
methods are found suitable for day to day analysis of linezolid in tablet dosage form. 
 
Keywords: Linezolid (LNZ), Differential spectrophotometry, Area under curve (AUC), UV 
Spectrophotometer 
 
Introduction 
Linezolid (LNZ)N-{[(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl] 
methyl} acetamideis oxazolidinone antibiotic. It inhibits bacterial protein synthesis by acting 
at an early step and a site different from that of other AMAs. It binds to 23s fraction of the 
50s ribosome and interfere with formation of the ternary N-formylmethionine-t-RNA-70s 
initiation complex. Binding of linezolid distorts the t-RNA binding site overlapping both 50s 
and 30s ribosomal subunits and stops protein synthesis before it starts (Tripathi, 2008). The 
empirical formula is C16H20FN3O4.  Its molecular weight is 337.346 g/mol. A literature review 
revealed that analytical simple spectrophotometry (Prasanthi et al., 2012), HPLC (Prasanti et 
al., 2012), HPTLC (Agrawal et al., 2003) and capillary electrophoresis (Michalska et al., 2008) 
have been established for the estimation of LNZ in tablet dosageform; but there was no 
mention of a method based on differential spectrophotometric and AUC determination of 
LNZ. The selectivity and accuracy of spectrophotometric analysis of samples containing 
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absorbing interferents may be markedly improved by the technique of difference 
spectrophotometry (Beckett et al.,2007). The essential feature of a difference 
spectrophotometric assay is that the measured value is the difference absorbance (∆A) 
between two equimolar solutions of the analyte in different chemical forms which exhibit 
different spectral characteristics (Beckett et al., 2007). AUC method based on selection of the 
wavelength range; where drug shows maximum absorbance. So in this study simple, rapid, 
precise, and accurate spectrophotometric methods have been developed for the 
determination of Linezolid in pharmaceutical dosage form and validated as per the ICH 
guideline. 
 
Materials and Methods 
Reagents and Materials 
Active Pharmaceutical Ingredient (API) of Linezolid supplied by ALEMBIC Pharmaceutical 
Limited, Vadodara, India). The pharmaceutical dosage form used in study was ALZOLID 
(label claim, LNZ 600 mg) manufactured by (ALEMBIC Pharmaceutical Limited, India). 
Methanol AR grade was purchased from (Finar Chemicals Pvt. Ltd, Ahmedabad, India), 
Sodium hydroxide (NaOH) pallets and Hydrochloric acid (36%) (Molychem, Mumbai, 
India) were used. 
 
Instrumentation 
UV-Visible double beam spectrophotometer (SHIMADZU 1700) with 10 mm matched 
quartz cells was used. All weighing were done on precision balance (REPTECH), and 
Ultrasonicsteri-cleaner was used (CYBERLAB) to degas the solutions. 
 
Preparation of standard solutions 
Stock solution of 1000 µg/ml of LNZ was prepared in methanol. From this solution 
100µg/ml solution was prepared by dilution with methanol. 
 
Preparation of 0.1N NaOH solution 
Take 0.4g of NaOH pallets and dissolve it in first 60ml of distilled water and then dilute 
upto 100ml with same. 
 
Preparation of 0.1N HCLsolution 
Take 0.85ml of concentrated hydrochloric acid(36%) and dissolve it in 100ml of distilled 
water. 
 
Development of the methods  
Method A: Differential Spectrophotometric Method 
Selection of analytical wavelength 
From stock solution of 100 µg/ml, take 1ml-1ml into two volumetric flasks and then make 
up the volume in one volumetric flask with 0.1N NaOH and in another volumetric flask 
with 0.1N HCL upto 10ml.Then spectra was scanned within range of 200-400nm by keeping 
acidic form (i.e. LNZ in 0.1N HCL) in reference cell and basic form (i.e. LNZ in 0.1N NaOH) 
in sample cell using 0.1N HCL in reference cell and 0.1N NaOH in sample cell as blank and 
then find out λ max (Figure 1). 
 
Method B: Area Under Curve (AUC) Method  
Selection of analytical wavelength range 
For the selection of analytical wavelength range, 6µg/ml solution of LNZ was prepared by 
appropriate dilution of standard stock solution and scanned in the spectrum mode from 200 
nm to 400 nm. From the spectra of drug, area under the curve in the range of 253.0-263.0 nm 
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(Figure 2) was selected for the analysis. The calibration curve was prepared in the 
concentration range of 4-12µg/ml at their respective AUC range. By using the calibration 
curve, the concentration of the sample solution can be determined. 
 
 
Fig. 1. λmax of Linezolid by Method A 
 
 
 
 
Fig. 2. Area under curve of linezolid (Method B) 
 
 
Validation Parameters 
The proposed method is validated according to the International Conference on 
Harmonization(ICH) guidelines. 
 
Linearity 
Aliquotes of 0.6ml, 0.9ml, 1.2ml, 1.5ml, 1.8ml were taken from 100µg/ml stock solution and 
transfer into 10ml volumetric flask and then volume was adjusted to the mark with 0.1N 
NaOH and 0.1N HCL. It gives 6, 9, 12, 15 and 18 µg/ml solutions. Then calibration curve 
was obtained by plotting absorbance →concentrations. Regression analysis was done for the 
slope, intercept and correlation coefficient values (Figure 3). 
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Repeatability 
The precision of the methods was assessed by repeated scanning (n = 6) and measurement of 
the absorbance of solutions of LNZ (12µg/ml) for Method A and LNZ (8µg/ml) for Method 
B without changing the parameters for the respective methods. The repeatability was 
expressed in terms of relative standard deviation (% RSD). 
 
 
FIG. 3. Linearity curve for differential spectroscopy of Linezolid 
 
Intermediate precision 
The intra-day and inter-day precision of the proposed method was done by analyzing the 
corresponding responses three times on the same day and on three different days over a 
period of one week for three different concentrations of standard solutions of LNZ (9, 12 and 
15µg/ml) for Method A and LNZ (6, 8 and 10 µg/ml) for Method B. The results were 
reported in terms of relative standard deviation (% RSD). 
 
Accuracy (% recovery) 
The accuracy of the method was performed by calculating %recovery of LNZ by the 
standard addition method. Known amounts of standard solutions of LNZ were added at 80, 
100 and 120% levels to pre-quantified sample solutions of LNZ (12µg/ml) for Method A and 
LNZ (8 µg/ml) for Method B. At each level of the amount three determinations were 
performed. The amount of LNZ was estimated by applying obtained values to relative 
standard deviation (% RSD). 
 
Sensitivity 
Limit of detection (LOD) and limit of quantitation (LOQ) were calculated as 3.3 σ/S and 
10σ/S respectively; where σ the standard deviation and S is the slop. 
 
Analysis of Tablet Formulation 
For analysis of commercial formulation; twenty tablets were weighed, average weight 
determined and crushed into finely powder. An accurately weighed quantity of powder 
equivalent to 100 mg of LNZ was transferred into 100 mL volumetric flask containing 50 mL 
methanol, gentle shaking was carried out for 5 min and ultrasonicated for 5 min. Then 
volume was adjusted to mark with same solvent and filtered through Whatmann filter 
paper (no.41) if necessary. From above solution 1.0 mL was transferred to 10 mL volumetric 
flask, volume was adjusted to the mark with same solvent. Now for Method A, take 1.5ml 
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from this solution into two volumetric flasks and then make up the volume in one 
volumetric flask with 0.1N NaOH and in another volumetric flask with 0.1N HCL upto 
10ml. Then spectra was scanned within range of 200-400nm by keeping acidic form (i.e. LNZ 
in 0.1N HCL) in reference cell and basic form (i.e. LNZ in 0.1N NaOH) in sample cell using 
0.1N HCL in reference cell and 0.1N NaOH  in sample cell as blank and then absorbance 
note at 258nm (λ max). For Method B, take 1.0ml from stock solution of tablet in volumetric 
flask and then make up the volume with methanol. The analysis was repeated for three 
times. The absorbance was putted in regression equation of calibration curve and amount of 
LNZ was found. There was no interference from the excipients commonly present in the 
tablets. The low % R.S.D. value indicated the suitability of this method for routine analysis 
of LNZ in tablet dosage form. 
 
Results and Discussion 
Method A is differential spectrophotometric method. In which absorption maxima (λ max) 
at 258.27 nm (Figure 1). The calibration curve was linear in concentration range of 4-
18µg/ml. Method B is the area under curve method. In this method the simple UV spectrum 
of Linezolid in methanol was obtained and area between two selected wavelengths 
measured. Area measured between 253nm and 263nm (Figure 2). The calibration curve was 
linear in concentration range of 4 – 18µg/ml. The proposed methods were found to be 
simple, sensitive, rapid, accurate, precise and economic for the routine analysis of linezolid 
in pharmaceutical formulations. Accuracy was determined by calculating the recovery, and 
the mean was determined (Table 1). Precision was calculated as repeatability, intraday and 
intermediate variation in term of % RSD for Linezolid. LOD values for Linezolid were found 
to be 0.1and 0.08µg/ml for method A and B respectively. LOQ values for Linezolid were 
found to be and 0.5 and 0.1µg/ml for method A and B respectively indicates sensitivity of 
the proposed methods. The methods were successfully used to determine the amounts of 
Linezolid present in tablets. The results obtained are in good agreement with the 
corresponding labeled amount (Table 2). Characteristic parameters and summary of 
validation parameters for both methods are given in Table 3. By observing the validation 
parameters, the methods were found to be sensitive, accurate and precise. Hence the 
methods can be employed for the routine analysis of Linezolid in tablet formulations. 
 
Table 1: Recovery Data for Proposed Methods 
 
Method  Level Amount of 
sample 
taken(µg/ml)  
Amount of 
std. added 
(µg/ml) 
Total 
amount 
(µg/ml)   
Statistical Analysis 
%Recovery   SDa % RSDb 
 
A 
80% 12 9.6 21.6 100.16 0.57 0.570912 
100% 12 12 24 100.05 0.71 0.709645 
120% 12 14.4 26.4 99.83 0.79 0.791345 
 
B 
80% 8 6.4 14.4 99.96 0.07 0.069965 
100% 8 8 16 100.05 0.14 0.139874 
120% 8 9.6 17.6 99.83 0.78 0.782537 
Method A is the Differential spectrophotometric method, Method B is the Area under curve method,                
SDa- standard deviation, RSDb-relative standard deviation 
 
Conclusion 
The proposed spectrophotometric methods provide simple, specific, precise, accurate and 
reproducible quantitative analysis for determination of LNZ in tablet dosage form. The 
methods were validated as per ICH guidelines in terms of linearity, accuracy, precision, 
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limits of detection (LOD) and quantification (LOQ) and ruggedness. The method can be 
used for routine analysis of LNZ in dosage form. 
 
Table 2: Results of Analysis of Tablet Formulation 
 
Method Formulation Label 
claim 
Estimated amount 
(mg)  ± SD 
%purity ± SDa 
(n=3) 
A 
B 
ALZOLID 
ALZOLID 
600mg 
600mg 
598.5 ± 0.82 
595.6 ± 1.48 
99.37 ± 0.68 
99.41 ± 0.27 
n is number of replicate and SDa - standard deviation. 
 
 
Table 3: Regression Analysis Data and Summary of Validation Parameters for the Proposed Methods 
 
Parameter Method A Method B 
Beer’s-Lambert’s range (µg/ml ) 4-18 4-18         
Regression equation (y =mx + c)  0.044x-0.041 0.048x-0.011 
Correlation coefficient (R2) 0.999 0.9993 
Slope (m) 0.044 0.048 
Intercept (c) -0.041 -0.011 
Precision (SDa ± %RSDb) 
Repeatability(n=6) 
 Intraday(n=3) 
 Intermediate(n=3) 
  
0.0092±1.90 
0.0075±1.51 
0.0077±1.16 
0.0026±0.66 
0.0023±0.78 
0.0055±1.39 
LODc(µg/ml) 0.18 0.08 
LOQd(µg/ml) 0.54 0.24 
 
aSD = Standard deviation. bRSD = Relative standard deviation. cLOD = Limit of detection. 
dLOQ = Limit of  quantification. n is number of determinations 
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